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Effectsof a ~-Agoniston MuscleProteinDegradation,EnzymeActivity,and Meat
TendernessinSteers
TommyL.WheelerandMohammadKoohmaralel~
Introduction
It is generallyacceptedthatmuscleproteinsare under
continualdegradationduringnormalgrowth. It has been
estimatedthat15to22%oftheanimal'stotalenergyexpen-
ditureis for thismuscleproteinturnover.Regulationof the
rateof muscleproteindegradationcould cause dramatic
changesin rateand efficiencyof musclegrowth. Despite
their importancein musclegrowth,the mechanismsand
controlof skeletalmuscleproteindegradationareunknown.
It has beenhypothesizedthatseveralenzymesystemsare
involvedatdifferentstagesofdegradation,andthatthecal-
painenzymesystem(whichoccursnaturallyinmuscle)may
initiateproteindegradationofthemusclefiber.
It has beendemonstratedthat~-agonistsincreasemus-
cle growth. At least a part of this growth results from
decreasedproteindegradation.~-agonistsalso decrease
meattendernessby increasingthe activityof the calpain
inhibitor,calpastatin.We knowthatthecalpainsystemhas
a majorroleinpostmortemtenderizationof meat. We also
hypothesizethatthe calpainsystemplaysa majorrole in
muscle proteindegradationin the growinganimal. The
objectiveof this studywas to determinetheeffectsof a ~-
agoniston muscle proteindegradation,muscleenzyme
activityandmeattendernessof steers.
Procedure
EightMARC III composite(1/4Hereford,1/4Angus,1/4
Pinzgauerand 1/4Red Poll)steersweighingapproximately
772 Ib were randomlyassignedto controlor ~-agonistfed
treatmentgroups. Animals were allowed unrestricted
access to a diet with or without3 ppmof the ~-agonist
4>44969 (from Merck Sharp and Dohme) in the diet. Two
consecutive24-hrurinecollectionsweretakenimmediately
before,and at 1, 3, 5, and 6 wk after~-agonistreatment
began. Urinaryconcentrationof N't-methylhistidine(N'tMH)
andcreatininewas measured.The skeletalmuscleprotein
mass of the steerswas estimatedfromurinarycreatinine
concentrations.N'tMHis a modifiedaminoacidfoundonly
in muscle(morethan90% in skeletalmuscle)so itcan be
used to measurethe rateand amountof skeletalmuscle
proteindegradation.At theendof the6 wk feedingperiod,
thesteerswereslaughteredaccordingto standardhumane
procedures.
Within30 min postmortem,loin musclesampleswere'
takenfromtheleftsidesformeasuringthecalpainenzymes
andtheirinhibitor,calpastatin,andthe lysosomalenzymes
cathepsinsBand B+L,andcystatin(cathepsininhibitor).At
24 hr postmortem,the loinmusclefromtherightsideswas
removedand cut intofive 1-in thick steaks and vacuum
packaged.Onesteakeachwasassignedto 1,3, 7, and14
days postmortemaging. Loin musclewas obtainedfrom
each shear force steakfor determinationof the Myofibril
FragmentationIndex(MFI),a measureofmeattenderness.
At the end of their respectiveagingtimes,the steaks
were broiledto 158°F internaltemperature.The steaks
'Wheeler is a research food technologist and Koohmaraie is the
researchleader,MeatsResearch Unit,MARC.
2'fheauthorswould liketo acknowledgethetechnicalassistanceof Peg
Ekeren, Sue Hauver,Kay Theer, Pat Tammen,Bob Lee, Nels Johnson
and KathySorensen.
'The fullreportof thisworkwill be publishedin the J. Anim. Sci., 1992.
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were chilled 24 hr, then .5-in diameter cores were removed
parallel to the muscle fibers for the measurement of shear
force (a mechanical measure of tenderness).
Results
The percentage of skeletal muscle protein degraded per
day, called fractional degradation rate (FOR, percentage/
day) was lower at 3 wk on trial and fractional accretion rate
(FAR, percentage/day) of skeletal muscle protein was
greater at 1, 3, 5, and 6 wk on trial compared to control
steers (Table 1). However, fractional synthesis rate (FSR,
percentage/day) was not different between treatment
groups. FAR = FSR + FOR. Several researchers have
shown a decrease in FOR as a result of ~-agonistfeeding,
while others have inferred a reduction in FOR from a failure
to find a change in FSR when accretion increased.
A convincing body of literatureindicates that the calpain
enzyme system has a major role in postmortem tenderiza-
tion of meat. It also has been hypothesized that the cal-
pains initiate muscle protein turnover by releasing myofila-
ments from the muscle fiber surface. Because ~-agonists
increase muscle growth, and reduce postmortemtenderiza-
tion, itwas of interestto determinethe effects on the calpain
enzyme system of feeding ~-agonist. At 0 hr (30 min post-
mortem), ~-calpain and m-calpain activities were not differ-
ent, but calpastatin activity was increased 60.0% in loin
muscle from ~-agonistfed steers (Table 2). After 7 days of
storage at 35°F, ~-calpain and calpastatin activities had
decreased relative to 0 hr, but again, only calpastatin was
changed due to feeding the ~-agonist (348% increase).
These data on ~-calpainand calpastatin are consistent with
previous findings.
Although not involved in postmortem tenderization, lyso-
somal cathepsins are hypothesized to be involved in protein
turnover. However, there were no significant differences in
cathepsin B, cathepsins B+L, or cystatin activities between
control and ~-agonistfed steers at 0 hr or 7 day postmortem
(Table 2).There was a decrease in cathepsins Band B+L
activitiesmeasured at 7 days compared to 0 hr postmortem.
Previous data indicate very inconsistent effects of ~-ago-
nists on cathepsin activities, implying they are not involved
in the rate limitingstep of muscle proteindegradation.
Consistent with the role of the calpain enzyme system in
postmortem tenderization, tenderness was dramatically
reduced in the loin muscle from ~-agonistfed steers (Fig. 1).
Shear force values decreased from 1 to 7 day postmortemin
control steers. However, shear force of ~-agonistfed steers
did not vary from 1 to 14 day postmortem. In addition, MFI
did not change in muscle from ~-agonistfed steers from 1 to
14 day postmortem,although MFI increased from 1 to 7 day
postmortemin control steers. The inhibitionof calpain activ-
ity by the high calpastatin activityin the treated steers com-
pletelyblocked normalpostmortemtenderization.
The mechanisms responsible for the increased muscle
growth are still very much in question. Increased synthesis,
decreased degradation, or both, have been reported as a
result of ~-agonist feeding. Our results indicate fractional
degradation rates (FOR) in treated steers had begun to
decline after 1 wk, became significantly lower at 3 wk, but
were again similar to controls by 6 wk of ~-agonistfeeding.
These results are consistent with previous reports indicating
the effectsof ~-agonistson proteindegradationare rapid,
and thendecline. Other researchershave statedthat~-
agonistsinducea short-termdecreasein degradationand
thatas degradationreturnsto normal,proteinsynthesis
increases. EstimatedFSR was notdifferentbetweencon-
trol and treatedsteers. However,FSR was numerically
higherat5 and6 wk. Thus,ourdatatendtosupporta
diphasic effect of ~-agoniston protein turnover.
Consideringthe different~-agonists,speciesto whichthey
are administered,varyingdosages and timeframes,and
methodologiesand timecourses for measuringFSR and
FOR,it is unlikelythatall discrepancieswill everbe com-
pletely reconciled. However,based on our data and a
broadinterpretationof previousdata(toaccountforvarying
experimentalconditions),it seems likelythat ~-agonists
exerttheireffecton musclegrowththroughbothdecreased
degradationandincreasedsynthesisof skeletalmusclepro-
teins. This is in contrastto increasedgrowthof normal,
rapidlygrowingmusclein whichbothsynthesisanddegra-
dation are increased, althoughthe former to a greater
extent.
The role of variousmuscleenzymesin muscleprotein
turnoverhas notbeen determined.However,the calpain
proteolytic system has been implicated in the initial, and
possibly rate limiting,steps of muscle protein degradation.
Furthermore, it has been clearly demonstrated that the cal-
pain enzyme system is largely responsible for the observed
variation in postmortem meat tenderness. Thus, it is
believed that the calpain system could regulate muscle pro-
tein degradation during both muscle growth and post-
mortem storage of meat. In support of this hypothesis, it
has been consistently demonstrated that ~-agonistfeeding
increases muscle calpastatin activity,thereby reducing post-
mortem proteolysis by calpain and meat tenderness.
Because postmortemproteolysis by calpain is reduced, it is
conceivable that calpain proteolysis in vivo also might be
reduced, thereby reducing the rate of muscle proteindegra-
dation (if calpain were involved in a rate limitingstep). Our
data are consistent with the previously reported increase in
calpastatin activity and reduced meat tenderness resulting
from~-agonistfeeding.Thecombinedobservationsof
decreased calpain proteolytic capacity and reduced FOR in
~-agonistfed steers compared to control animals supports
this hypothesis. A greater understandingof the in vivo reg-
ulation of the calpain system is needed to further evaluate
this hypothesis.
Table1-Effects of l3-agonlstonskeletalmuscleproteinturnoverofgrowingsteers
a Fractionaldegradationrate01skeletalmuscleprotein.
b Fractionalaccretionrate01skeletalmuscleprotein.
e Fractionalsynthesisrate01skeletalmuscleprotein.FSR-FDR+FAR
* Treatmentdifferenceswithinweekweresignilicantat(P <.05).
Table2-Effects of l3-agonlstfeedingandtimepostmortemonmuscleenzymeactivitiesInloinmuscle
a Lowcalciumrequiringcalpain.
b Highcalciumrequiringcalpain.
e Totalactivity.
d Measuredas theratio01B+l activityaltertobelorecystatin(s)removal.
" 3 pprn01fl-agonistlor6 wk.
* Treatmentdifferenceswithinpostmortemtimeweresignificant(P <.05).
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Owk 1wk 3wk 5wk 6wk
-
Control Treated Control Treated Control Treated Control Treated Control Treated
FORa,%/day 1.13 1.14 1.24 1.09 2.25 1.77* 1.81 1.77 1.41 1.56
FARb,%/day .48 .63* .32 .50* .27 .45* .12 .36*
FSRe,%/day 1.72 1.72 2.57 2.27 2.08 2.22 1.53 1.92
Cathepsin Cathepsins
I1-Calpaina m-Calpaina Calpastatinb Be B+Le Cystatind
Control
oday 1.05 1.44 3.72 46.0 235.5 3.9
7 day .02 1.27 .69 33.8 193.5 4.5
Treated"
oday 1.15 1.51 5.95* 36.5 215.5 4.3
7 day .08 1.27 3.09* 26.8 181.5 4.6
-- ----
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Figure1- The effectsoffeeding3 ppmof ~-agonisttogrowingsteersfor6 wk on (A)shearforceand(B)MyofibrilFragmentationIndexdur-
ingpostmortemstorageat35°F.
. Treatmentdifferenceswithinpostmortemtimeweresignificant(P< .05).
.bc Meansforpostmortemagingtimeswithinatreatmentwithacommonsuperscriptarenotdifferent(P>.05).
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